본문으로 건너뛰기
cccskills
무료GitHub에 공개

es-cushing-re-evaluate-pituitary-hormone-deficiencies-postop

This skill recommends re-evaluating the need for treatment of other pituitary hormone deficiencies in the postoperative period following surgical intervention for Cushing's syndrome. It is triggered when assessing a post-op CS patient for ongoing pituitary function, evaluating for hypopituitarism, or checking HPA axis recovery with morning cortisol/ACTH stimulation tests and pituitary MRI within 1–3 months.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

설치 방법 보기

포함된 파일(1)

  • SKILL.md3.0 KB

SKILL.md(원문)

설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.

Re-Evaluating Need for Treatment of Other Pituitary Hormone Deficiencies in Postoperative Period

STEP 1 — Gather Information

Collect postoperative clinical data (symptoms of fatigue, weight loss, hypotension, cold intolerance, loss of libido, etc.) and laboratory studies: morning serum cortisol, ACTH stimulation test or insulin-induced hypoglycemia test, free T4, TSH, prolactin, LH/FSH, estradiol/testosterone, IGF-1, and serum sodium; obtain postoperative pituitary MRI within 1–3 months if transsphenoidal surgery performed.

STEP 2 — Rule In / Rule Out

Determine whether there is biochemical evidence of pituitary hormone deficiency (e.g., low morning cortisol with subnormal ACTH response, low free T4 with inappropriately normal/low TSH, low prolactin, low LH/FSH with low sex steroids, low IGF-1) versus normal function.

STEP 3 — Classify or Stratify

Classify which pituitary axes are deficient (ACTH, thyroid, gonadal, growth hormone) and assess severity (mild, moderate, severe) based on hormone levels and clinical symptoms.

STEP 4 — Decide

Initiate appropriate hormone replacement for each deficient axis (glucocorticoid, levothyroxine, sex steroids, GH if indicated), provide patient education on adrenal insufficiency and stress dosing, and schedule follow‑up testing to assess for potential recovery of axis function.

Clinical Guardrails / Mimics / Pitfalls

Do not discontinue glucocorticoid replacement without confirming HPA axis recovery; avoid overlooking central hypothyroidism or hypogonadism because symptoms may be subtle; do not assume all deficiencies are permanent—re‑evaluate periodically; avoid giving estrogen/testosterone without confirming gonadal axis deficiency; be cautious of precipitating adrenal crisis during illness if glucocorticoid replacement is inadequate.

Concrete Clinical Example

A 48‑year‑old woman undergoes transsphenoidal resection of an ACTH‑secreting pituitary macroadenoma for Cushing's disease. On postoperative day 7 she reports fatigue and dizziness. Labs show morning cortisol 3 µg/dL (low), subnormal response to ACTH stimulation, free T4 0.6 ng/dL with TSH 2 µIU/mL (inappropriately normal), prolactin <2 ng/mL, IGF‑1 80 ng/mL (low). She is started on hydrocortisone 15 mg/day divided, levothyroxine 75 µg/day, and referred for endocrine follow‑up; testosterone replacement is deferred until gonadal axis is further assessed.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

리뷰

아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.

댓글

로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.

아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.

보내면 바로 공개됩니다. 이메일 주소나 전화번호 같은 개인 정보는 쓰지 마세요. URL은 2개까지입니다.

0 / 1,000자

이 양식은 reCAPTCHA로 보호되며 Google 개인정보처리방침 및 서비스 약관이 적용됩니다.

같은 저장소의 스킬

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

dromlakhani의 스킬 모두 보기

이 스킬의 문제 신고